Brevan Howard Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Buy
62,412
+43,981
+239% +$10.3M 0.12% 125
2026
Q1
$4.51M Sell
18,431
-36,591
-67% -$8.52M 0.04% 272
2025
Q4
$11.4M Sell
55,022
-28,623
-34% -$5.66M 0.12% 104
2025
Q3
$15.5M Sell
83,645
-58,074
-41% -$9.95M 0.07% 86
2025
Q2
$21.6M Buy
141,719
+77,694
+121% +$11.9M 0.13% 84
2025
Q1
$10.6M Buy
+64,025
New +$10M 0.1% 55
2024
Q4
Sell
-19,061
Closed -$3.09M 1247
2024
Q3
$3.09M Sell
19,061
-7,825
-29% -$1.25M 0.02% 190
2024
Q2
$3.93M Buy
26,886
+21,779
+426% +$3.24M 0.04% 119
2024
Q1
$808K Buy
+5,107
New +$813K 0.01% 318
2023
Q4
Sell
-1,983
Closed -$309K 1056
2023
Q3
$309K Buy
+1,983
New +$327K ﹤0.01% 238
2013
Q4
Sell
-4,829
Closed -$445K 31
2013
Q3
$419K Hold
4,829
0.2% 32
2013
Q2
$415K Buy
+4,829
New +$410K 0.07% 29

Other funds holding JNJ

Brevan Howard Capital Management's JNJ Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Johnson & Johnson (JNJ) stake by 239% in Q2 2026, buying an estimated $10.3M and bringing the position to 62,412 shares worth $15.9M. The position accounts for 0.12% of the portfolio, ranked #125.

Brevan Howard Capital Management first reported a position in JNJ in Q2 2013 and has held it in 12 quarters since. The position peaked at $21.6M in Q2 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Brevan Howard Capital Management held 62,412 shares of Johnson & Johnson worth $15.9M as of Q2 2026.
  • Brevan Howard Capital Management bought 43,981 Johnson & Johnson shares in Q2 2026, an estimated $10.3M.
  • Johnson & Johnson made up 0.12% of Brevan Howard Capital Management's portfolio in Q2 2026, its #125 holding.
  • Brevan Howard Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 12 quarters since.
  • Brevan Howard Capital Management's Johnson & Johnson position peaked at $21.6M in Q2 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.